首页> 美国政府科技报告 >Study to Determine the Changes of Physician Prescribing Patterns of AntimicrobialAgents, Omeprazole and H2-Receptor Antagonists for Peptic Ulcer Disease Two Years Following the NIH Consensus Conference on 'H. Pylori'

【24h】

Study to Determine the Changes of Physician Prescribing Patterns of AntimicrobialAgents, Omeprazole and H2-Receptor Antagonists for Peptic Ulcer Disease Two Years Following the NIH Consensus Conference on 'H. Pylori'

机译：在美国国立卫生研究院共识会议之后两年，确定消化性溃疡病的抗菌药物，奥美拉唑和H2受体拮抗剂的医师处方模式变化的研究幽门螺杆菌”

获取原文

页面导航

摘要
著录项
相似文献
相关主题

摘要

The study evaluates the prescribing patterns of physicians for the treatment ofpeptic ulcer disease (PUD). Its particular focus is whether recommendations of a February 1994 National Institutes of Health (NIH) Consensus Development Conference advocating the use of antimicrobial agents for peptic ulcer patients with Helicobactor pylori infection were coincident with a change in physician prescribing patterns. The study uses computerized Pennsylvania Medicaid administrative data from January 1993 through February 1996 to evaluate prescribing patterns in the year prior and the two years following the NIH conference (12,737 patient records in all). Seven major therapeutic drug classes were analyzed: antimicrobial agents, H2-receptor antagonists, antisecretory agents, bismuth subsalicylate, sucralfate, misoprostol, and antacids.

著录项

作者
Thamer, M.; Ray, N. F.; Henderson, S.; Rinehart, C.;
展开▼
作者单位

展开▼
年度 1997
页码 1-120
总页数 120
原文格式 PDF
正文语种 eng
中图分类工业技术;
关键词
Ulcers; Gastrointestinal diseases; Peptic ulcers; Antimicrobial agents; Drugtherapy; Physicians;

机译：溃疡;胃肠疾病;消化性溃疡;抗菌药物;药物治疗;内科医生;

相似文献

外文文献
中文文献
专利

1. Helicobacter pylori in Peptic Ulcer Disease: Report of an NIH Consensus Conference [J] . Alfred O. Berg Journal of the American Board of Family Medicine: JABFM . 1996,第3期

机译：消化性溃疡疾病中的幽门螺杆菌：美国国立卫生研究院共识会议的报告
2. Are twelve days of omeprazole, amoxicillin and clarithromycin better than six days for treating H. pylori infection in peptic ulcer and in non-ulcer dyspepsia? [J] . Gisbert JP, Hermida C, Pajares JM Hepato-gastroenterology. . 2001,第41期

机译：奥美拉唑，阿莫西林和克拉霉素的十二天治疗消化性溃疡和非溃疡性消化不良的幽门螺杆菌感染是否比六天好？
3. Comparative Study Between Metronidazole, Amoxycilin, Omeprazole Based Therapy and Levofloxacin, Amoxycilin, Omeprazole Based Therapy for Helicobactor Pylori Eradication in Peptic Ulcer Disease [J] . Abdur Rahim Miah, ASMA Raihan, Assistant Professor of Gastroenterology Sir Salimulla Medical College DhakaBangladesh, Journal of Chittagong Medical College Teachers Association . 2009,第2期

机译：甲硝唑，阿莫西林，奥美拉唑治疗与左氧氟沙星，阿莫西林，奥美拉唑治疗消化性溃疡的幽门螺杆菌治疗之间的比较研究
4. Further Experience with H2-Receptor Antagonists in Peptic Ulcer Disease and Progress in Histamine Research [O] . 1981

机译：H2-受体拮抗剂在消化性溃疡疾病中的进一步经验以及组胺研究的进展
5. Omeprazole, Furazolidone, and Tetracycline: an eradication treatment for resistant H. pylori in Brazilian patients with peptic ulcer disease Omeprazol, Tetraciclina e Furazolidona, um tratamento para erradicação do H. pylori resistente em pacientes ulcerosos do Brasil [O] . Fernando Marcuz Silva, Jaime Natan Eisig, Ethel Zimberg Chehter, 2002

机译：奥美拉唑，呋喃唑酮和四环素：在巴西消化性溃疡疾病患者中根除耐药性幽门螺杆菌的方法奥美拉唑，四环素和呋喃唑酮在巴西用于根除溃疡患者的耐药性幽门螺杆菌的方法

Study to Determine the Changes of Physician Prescribing Patterns of AntimicrobialAgents, Omeprazole and H2-Receptor Antagonists for Peptic Ulcer Disease Two Years Following the NIH Consensus Conference on 'H. Pylori'

摘要

著录项

相似文献

相关主题

期刊订阅